Baligh Yehia of the Perelman School of Medicine comments on the progress made in HIV-treatment research.
Penn Annenberg Study: Americans Roundly Reject Tailored Political Advertising as Politicians Embrace it
A large majority of Americans are dead-set against the practice of tailored political advertising at the very time in the 2012 election that the activity is seeing unprecedented growth. In fact, a high percentage of Americans dislike tailored political advertising so much they say their likelihood of voting for a candidate they support would decrease if they find out the candidate engages in it.
The percentage of HIV patients taking antiretroviral drugs who experienced the full benefit of the drugs jumped from 45 percent of 72 percent during the past decade, a figure that is lower than previous estimates.
Researchers from the Wharton School are cited for a collaborative study about volunteering.
University of Pennsylvania researchers are helping to provide a snapshot of how Iranians access news and information and what technologies Iranians use to learn about current events under restrictive laws.
Susan Ellenberg of the Perelman School of Medicine comments on a study about newer cancer drugs.
PHILADELPHIA — In June, the North Carolina legislature attempted to block a group of local scientists’ findings about how climate change could impact the state via sea-level rise. The new legislation would, for a time, prohibit the state’s coastal developers from using anything but linear estimates for rates of sea-level rise, where levels would go up by around 20 centimeters over the next century.
While clinical trial results are being released regarding drugs intended to decrease amyloid production - thought to contribute to decline in Alzheimer's disease - clinical trials of drugs targeting other disease proteins, such as tau, are in their initial phases.
Uri Simonsohn of the Wharton School discusses scientific papers that have to be retracted.